Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
11:22:23 EDT Sun 29 Mar 2026
Enter Symbol
or Name
USA
CA



News last 24 hour(s) - 14 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2026-03-29 10:00U:AZINews ReleaseAutozi Internet Technology (Global) Ltd. Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities
2026-03-29 06:15U:CXLFFNews ReleaseChina Xlx Announces 2025 Annual Results Deepening Efforts in Reducing Costs, Enhancing Efficiency, Strengthening Competitiveness Through Differentiation and Driving Marketing Transformation
2026-03-28 22:07U:SKTCFNews ReleaseSkychain Technologies Inc. Provides Update on Financial Position, Asset Status, and Ongoing Transition Issues
2026-03-28 20:20U:ELEKNews ReleaseWhere Speed Meets Opportunity - a New Era in Electric Mobility Begins
2026-03-28 16:45U:AMGNNews ReleaseREPATHA(TM) CUTS RISK OF FIRST MAJOR CARDIOVASCULAR EVENTS BY 31% IN HIGH-RISK PATIENTS WITHOUT KNOWN SIGNIFICANT ATHEROSCLEROSIS
2026-03-28 15:15U:LLYNews ReleasePhase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity
2026-03-28 15:00U:TAKNews ReleaseTakeda's Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
2026-03-28 15:00U:ROIVNews ReleaseNew England Journal of Medicine Publishes Positive Phase 3 VALOR Trial Results of Brepocitinib in Dermatomyositis
2026-03-28 15:00U:MLTXNews ReleaseMoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
2026-03-28 15:00U:INCYNews ReleaseIncyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
2026-03-28 15:00U:BIIBNews ReleaseBiogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
2026-03-28 14:45U:CORTNews ReleaseCorcept Presents Data from MOMENTUM Trial at American College of Cardiology Annual Scientific Session
2026-03-28 13:30U:ALMSNews ReleaseAlumis' Envudeucitinib Delivers Early and Robust Improvements in Skin Clearance, Quality of Life and Psoriasis Symptoms in Two Phase 3 Trials, Underscoring Its Potential as a Leading Oral Therapy for Plaque Psoriasis
2026-03-28 12:36U:NKTRNews ReleaseData from Phase 2b REZOLVE-AD and REZOLVE-AA Studies of Rezpegaldesleukin Presented at 2026 American Academy of Dermatology Annual Meeting